Skip to main content

Individuals With BAP1 Have High Rate of Nail Abnormalities

Medically reviewed by Carmen Pope, BPharm. Last updated on May 20, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, May 20, 2024 -- Individuals with BRCA1-associated protein (BAP1) have a high rate of nail abnormalities consistent with onychopapillomas, according to a study published online May 17 in JAMA Dermatology to coincide the annual meeting of the Society for Investigative Dermatology, held from May 15 to 18 in Dallas.

Alexandra Lebensohn, from the National Institutes of Health in Bethesda, Maryland, and colleagues examined the prevalence of nail abnormalities in individuals with pathogenic germline variants in BAP1 in a prospective cohort study. Data were included for 47 participants, aged 13 to 72 years, from 35 families.

The researchers found that 41 patients (87.2 percent) had nail abnormalities, including leukonychia, splinter hemorrhage, onychoschizia, and distal nail hyperkeratosis. Overall, 39 patients (83.0 percent) had clinical findings consistent with onychopapilloma, including 35 of 40 individuals aged 30 years or older (87.5 percent). Five patients underwent nail bed biopsy, which was consistent with onychopapilloma. In nearly all patients with nail involvement (38 of 39 [97.4 percent]), polydactylous involvement with onychopapillomas was detected.

"Given the uncertain biologic potential of the nail lesions, clinical photography and periodic observation is prudent to monitor lesions, and patients should be advised to return for reevaluation if a significant change occurs in the nail or nail pain develops," the authors write.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

THURSDAY, May 30, 2024 -- Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published...

Tattoos May Increase Risk of Malignant Lymphoma

WEDNESDAY, May 29, 2024 -- Tattoo exposure is associated with an increased risk of several malignant lymphoma subtypes, according to a study published online in the June issue...

Acrochordons May Be Marker for Metabolic Disease in Children

TUESDAY, May 21, 2024 -- In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.